Advertisement

Platelet Rich Plasma Practical Use in Non-Surgical Musculoskeletal Pathology

  • Adam WegleinEmail author
  • Steve Sampson
  • Danielle Aufiero
Chapter
Part of the Lecture Notes in Bioengineering book series (LNBE)

Abstract

Platelet Rich Plasma is a new emerging treatment modality with fantastic potential to heal both in the surgical and non surgical arenas. This chapter focuses on the Non- surgical applications of Platelet Rich Plasma, primarily in the clinic setting. We have reviewed the current status of PRP preparation, PRP sub types and clinical utilization. It is our intent that this chapter will serve as a guide to those interested in Conservative utilization of PRP in musculoskeletal Medicine.

Keywords

Nucleus Pulposis Platelet Rich Plasma Plantar Fasciitis Tennis Elbow Platelet Concentration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Sanchez M et al (2005) Application of autologous growth factors on skeletal muscle healing. In: Proceedings of 2nd world congress on regenerative medicine, Leipzig, Germany, 18–20 May 2005Google Scholar
  2. Almekinders LC et al (1998) Etiology, diagnosis and treatment of tendonitis: an analysis of the literature. Med Sci Sports Exer 30(8):1183–1190CrossRefGoogle Scholar
  3. Anitua E, Sanchez M, Nurden AT et al (2007) Platelet released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology 46:1769–1772CrossRefGoogle Scholar
  4. Anitua E, Sánchez M, Orive G, Andía I (2008) Delivering growth factors for therapeutics. Trends Pharmacol Sci 29:37–41CrossRefGoogle Scholar
  5. Aspenberg P, Virchenko O (2004) Platelet concentrate injection improves Achilles tendon repair in rats. Acta Othop Scand 75(1):93–99CrossRefGoogle Scholar
  6. Berghoff W, Pietrzak W, Rhodes R (2006) Platelet-rich plasma application during closure following total knee arthroplasty. Orthopedics 29:590–598Google Scholar
  7. Chen W et al (2006) Tissue-engineered intervertebral disc and chondrogenesis using human nucleus pulposus regulated through TGF-beta 1 in platelet-rich-plasma. J Cell Physiol 209(3):744–754CrossRefGoogle Scholar
  8. Cook JL, Anderson CC, Kreeger JM et al (2000) Effects of human recombinant interleukin-1 beta on canine articular chondrocytes in three-dimensional culture. Am J Vet Res 61:766–770CrossRefGoogle Scholar
  9. Curtis HM et al (2011) Accuracy of ultrasound-guided and palpation-guided knee injections by an experienced and less-experienced injector using a superolateral approach: a cadaveric study. PM&R 3(6):507–515CrossRefGoogle Scholar
  10. de Mos M et al (2008) Can platelet rich plasma enhance tendon repair? A cell culture study. Am J Sports Med 36:1171–1178CrossRefGoogle Scholar
  11. Dohan Ehrenfest DM et al (2009) Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte and platelet-rich fibrin (L-PRF). Trends Biotechnol 27(3):158–167CrossRefGoogle Scholar
  12. El-Sharkawy H et al (2007) Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol 78(4):661–669CrossRefGoogle Scholar
  13. Everts PAM, Devilee R, Mahoney C et al (2006a) Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee arthroplasty. Acta Anaesthesiol Scand 50:593–599CrossRefGoogle Scholar
  14. Everts PAM, Knape JTA et al (2006b) Platelet rich plasma and platelet gel, a review. J Extra Corpor Techn 38:174–187Google Scholar
  15. Ferrari M, Zia S, Valbonesi M, Henriquet F et al (1987) A new technique for hemodilution, preparation of autologous platelet-rich plasma and intraopetative blood salvage in cardiac surgery. Int J artif Org 10:47–50Google Scholar
  16. Frisbie D, Kawcak C, Werpy N, Park R, Wayne CW (2007) Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis. Am J Vet Res 68(3):290–296Google Scholar
  17. Gardner MJ, Demetrakopoulos D, Klepchick P et al (2007) The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty. An analysis of the haemoglobin, narcotic requirement and range of motion. Int Orthop 31:309–313CrossRefGoogle Scholar
  18. Goldring MB (2000) The role of the chondrocyte in osteoarthritis. Arthritis Rhuem 43:1916–1926CrossRefGoogle Scholar
  19. Grøgaard B, Gerdin B, Reikerås O (1990) The polymorphonuclear leukocyte: has it a role in fracture healing? Arch Orthop Trauma Surg 109(5):268–271CrossRefGoogle Scholar
  20. Hunziker EB, Driesang IM, Morris EA (2001) Chondrogenesis in cartilage repair is induced by members of the transforming growth factor-beta superfamily. Clin Orthop Relat Res 391(suppl):S171–S181CrossRefGoogle Scholar
  21. Karpie JC, Chu RC (2007) Lidocaine exhibits dose- and time-dependent cytotoxic effects on bovine articular chondrocytes in vitro. Am J Sports Med 35(10):1621–1627CrossRefGoogle Scholar
  22. Kon E, Filardo G, Presti ML et al (2007) Utilization of platelet-derived growth factors for the treatment of cartilage degenerative pathology. Paper presented at the international Cartilage Repair Society meeting, Warsaw, Poland, October 2007Google Scholar
  23. Kon E, Buda R, Filardo G et al (2010) Platelet rich plasma: intra articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 18:472–479CrossRefGoogle Scholar
  24. Kumar V et al (2005) Pathologic basis of disease, 7th edn. St. Louis, SaundersGoogle Scholar
  25. Marx RE (2001) Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 10(8):225–228MathSciNetCrossRefGoogle Scholar
  26. Mastangelo A, Vavken P, Fleming B, Harrison S, Murrary M (2011) Reduced platelet concentration does not harm PRP affectiveness for ACL repair in a porcine in vivo model. J Orthop Res 29(7):1002–1007CrossRefGoogle Scholar
  27. Mei-Dan O et al (2010) Autologous platelet-rich plasma: a revolution in soft tissue sports injury management? Phys Sports Med 4(38):127–132CrossRefGoogle Scholar
  28. Mishra A, Pavelko T (2006) Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 10(10):1–5Google Scholar
  29. Murray M et al (2007) Enhanced histologic repair in a central wound in the anterior cruciate ligament with a collagen-platelet-rich plasma scaffold. J Orthop Res 25(8):1007–1017CrossRefGoogle Scholar
  30. Nagae M et al (2007) Intervertebral disc regeneration using platelet-rich plasma and biodegradable gelatin hydrogel microspheres. Tissue Eng 13(1):147–158CrossRefGoogle Scholar
  31. Nakagawa K, Sasho T, Arai M et al (2007) Effects of autologous platelet-rich plasma on the metabolism of human articular chondrocytes. Paper presented at the international Cartilage Repair Society meeting, Warsaw, Poland, October 2007Google Scholar
  32. Peerbooms J, Sluimer J, Bruigin D, Gosens T (2010) Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. AJSM 38(2):255–262Google Scholar
  33. Pietrzak WS, Eppley BL (2005) Platelet rich plasma: biology and new technology. J Craniofac Surg 16:1043–1054CrossRefGoogle Scholar
  34. Sampson S, Gerhardt M, Mandelaum B (2008) Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med 1:165–174CrossRefGoogle Scholar
  35. Sampson S, Reed M, Silvers H, Meng M, Mandelbaum B (2010) Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am J Phys Med Rehabil 89(12):961–969CrossRefGoogle Scholar
  36. Sampson S et al (2011) Platelet-rich plasma therapy as a first line treatment for severe Achilles tendon tear: a case report. Int J Ther Rehabil 18(2):101–106Google Scholar
  37. Sawamura K et al (2009) Characterization of in vivo effects of platelet-rich plasma and biodegradable gelatin hydrogel microspheres on degenerated intervertebral discs. Tissue Eng Part A 15(12):3719–3727CrossRefGoogle Scholar
  38. Scott A, Khan KM, Roberts CR, Cook JL, Duronio V (2004) What do we mean by the term “inflammation”? A contemporary basic science update for sports medicine. Br J Sports Med 38(3):372–380CrossRefGoogle Scholar
  39. Smith C et al (2008) The inflammatory response to skeletal muscle injury: illuminating complexities. Sports Med 38(11):947–969CrossRefGoogle Scholar
  40. Tate KS, Crane D (2010) Platelet rich plasma grafts in musculoskeletal medicine. J Prolother 2(2):371–376Google Scholar
  41. Toumi H, Best TM (2003) The inflammatory response: friend or enemy for muscle injury? Br J Sports Med 37(4):284–286Google Scholar
  42. Troiano M, Schoenhaus H (2009) A closer look at Orthobiologics for tendon Repair. Podiatry Today 22(10)Google Scholar
  43. Van Buul G, Koevoet W, Kops N, Verhaar J, Weinans H, Bernsen M, Van Osch G (2011) Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. AJSM 39(11):2362–2370Google Scholar
  44. Wang-Saegusa A, Cugat R, Ares O, Seijas R, Cuscó X, Garcia-Balletbó M (2011) Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Arch Orthop Trauma Surg 131(3):311–317CrossRefGoogle Scholar
  45. Weglein A (2011) Focused review: current trends in platelet rich plasma injection treatments. J Neurosurg Rev 1(s1):95–97Google Scholar
  46. Weglein A (2011b) Neural Prolotherapy. J Prolother 3(2):639–643Google Scholar
  47. Woodell-May J, Matuska A, Oyster M, Welch Z, O’Shaughnessey K, Hoeppner J (2011) Autologous protein solution inhibits MMP-13 production by IL-1β and TNFα-stimulated human articular chondrocytes. J Orthop Res 29(9):1320–1326CrossRefGoogle Scholar
  48. Wu W, Chen F, Liu Y et al (2007) Autologous injectable tissue-engineered cartilage by using platelet-rich plasma: experimental study in a rabbit model. J Oral Maxillofac Surg 65:1951–1957CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Adam Weglein
    • 1
    • 2
    Email author
  • Steve Sampson
    • 3
    • 4
    • 5
  • Danielle Aufiero
    • 3
    • 6
    • 7
  1. 1.Regenerative Ortho Med ClinicHoustonUSA
  2. 2.Houston Medical SchoolUniversity of Texas Health Science CenterHoustonUSA
  3. 3.The Orthohealing CenterLos AngelesUSA
  4. 4.The Orthobiologic Institute (TOBI)Los AngelesUSA
  5. 5.David Geffen School of Medicine at UCLALos AngelesUSA
  6. 6.Physical Medicine and RehabilitationWestern University of Health SciencesPomonaUSA
  7. 7.Adjunct Clinical ProfessorTouro UniversitySan FraniscoUSA

Personalised recommendations